Search

everythinglearnresearchcommunity

for

Search:↓

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

GKLF/KLF4 and Sp1 control Keratin 19 gene activity, influencing cancer-related changes.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

CD99 is highly present in certain skin cells and could help treat skin conditions.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

LGD1069 effectively prevents breast tumors in mice without toxicity.

ITK inhibitors may effectively treat alopecia areata.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

A method was found to select hair follicle stem cells, and beta-catenin helps them grow and change.